We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
23 hedge funds and large institutions have $1.49M invested in Plus Therapeutics in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0.12% less ownership
Funds ownership: 0.34% → 0.21% (-0.12%)
8% less funds holding
Funds holding: 25 → 23 (-2)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
75% less capital invested
Capital invested by funds: $5.92M → $1.49M (-$4.43M)
Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$186K |
| 2 |
Millennium Management
New York
|
+$82.4K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$26.4K |
| 4 |
Mercer Global Advisors
Denver,
Colorado
|
+$19.4K |
| 5 |
MFS
Miller Financial Services
Marshall,
Michigan
|
+$15.2K |
Top Sellers
| 1 |
LGM
L1 Global Manager
Melbourne,
|
-$1.17M |
| 2 |
Jane Street
New York
|
-$525K |
| 3 |
VF
Virtu Financial
New York
|
-$254K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$239K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$94.8K |
